Loss of heterozygosity (LOH) of PTPRJ has been detected in breast, lung and colon cancers and expression has been shown to induce differentiation and to inhibit growth of breast cancer cells, indicating a function as tumour suppressor gene [26-28]. Here, PTPRJ is linked to breast carcinoma.